Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Comparative analysis of the immunomodulatory effects of extracellular vesicles from canine placental and adipose-derived mesenchymal stem cells.

Ha JH., Ahn JO., Choi JH., Kim SH., Chung JY.

Animal Study on Immune Modulation, published in Am J Vet Res (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Am J Vet Res (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41702062
DOI
10.2460/ajvr.25.12.0426

Abstract (original English)

Objective To compare the immunomodulatory capacities of canine placenta-derived mesenchymal stem cells (PMSCs; MSCs) and adipose-derived MSCs (ADMSCs) as well as the effects of their extracellular vesicles (EVs) on peripheral blood mononuclear cells (PBMCs). Methods PMSCs and ADMSCs were isolated and characterized. The PBMCs were cocultured with each isolated MSC. PBMC viability was assessed by trypan blue, and CD4 expression and PBMC proliferation were analyzed by flow cytometry. Inflammatory cytokines in the supernatants were measured using an ELISA. In addition, each type of MSC-derived EV was extracted and incubated with PBMCs. Subsequently, the same analyses used in the MSC experiments were performed. Statistical analyses used SPSS 26 with the significance set at P Results In MSC experiments, PMSC group exhibited the highest CD4 expression, and PBMC proliferation was also lowest in PMSC group. PBMC viability was significantly lower in PMSC group. A comparison of the inflammatory cytokine concentrations showed similar IL-2 and IL-10 levels in the groups, whereas TNF-α was significantly lower in PMSC group. In EV experiments, the PMSC EV had a greater ability to inhibit PBMC proliferation than the ADMSC EV, whereas CD4 expression showed no difference. PBMC viability and TNF-α concentration were lowest in PMSC EV group, whereas IL-2 concentration was lowest in ADMSC EV group.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsMesenchymal Stem CellsFemaleDogsExtracellular VesiclesAdipose TissuePlacentaPregnancyLeukocytes, MononuclearCytokines

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research